Search Result Products - CapitalBiotech Co., Ltd.

All Related Products Other Content

Genetic Testing for Blood Cancer This test can detect 232 genes associated with blood cancers, and covers all types of leukemia: AML/ALL/CML/CLL/MDS/MPN and various lymphomas.
The Disease Susceptibility Genetic Test-Anti-Cancer Package C This test is based on biochip technology. By detecting TP53, CYP1A1 and XRCC1, it assesses their impact on the risk of tumors.
Karyotype Analysis Karyotyping can be used to investigate cytogenetic classification, interspecies relationships, chromosome number and structural variation.
The Disease Susceptibility Genetic Test-Alzheimer's Disease This test is based on biochip technology and evaluates the risk of Alzheimer's disease by detecting innate susceptibility genes of the human body.
CMA Detection CMA (Chromosomal Microarray Analysis) is a high-resolution, high-throughput molecular karyotyping technique for detecting copy number variation in human genomic DNA.
Individualized Chemotherapy Drugs For Cancers (10 Genes) This test can detect gene polymorphisms related to 13 common chemotherapeutic drugs, and assist clinicians in formulating individualized chemotherapy medication plans.
MTB Drug Resistant Detection MDR-TB disease can be quickly diagnosed by using gene chip technology to quickly test for resistance to rifampicin and isoniazid, two of the most important first-line anti-TB drugs.
Folic Acid Utilization Ability Genetic Detection The genetic testing for folic acid utilization can understand the body's ability to utilize folic acid from the gene level, and to realize the personalized supplementation of folic acid, thereby preventing occurrence of disease.
The Disease Susceptibility Genetic Test-Thrombotic Disorders (5 Items) This test is based on biochip technology and evaluates the risk of five thrombotic diseases from a genetic perspecitve.
Y Chromosome Microdeletion Gene Detection The spermatogenesis disorders caused by genetic factors such as chromosomal abnormalities and gene mutations account for more than 30%, of which the Y chromosome microdeletion is the second largest genetic factor leading to male infertility.
Individualized Medication Guidance for Cancer (800 Genes) This test detects 800 genes, helping doctors formulate professional and individualized treatment plans for patients.
The Disease Susceptibility Genetic Test-Diabetes (4 Items) This test is based on biochip technology, from a genetic perspective, assesses the risk of type 2 diabetes and its complications, as well as the sensitivity to hypoglycemic drugs.
Tandem Mass Spectrometry Screening for Genetic Metabolic Diseases Tandem Mass Spectrometry (MS/MS) is a powerful technique for the analysis of complex mixtures such as body fluids, cell lysates or biopsies.
The Disease Susceptibility Genetic Test-Cardiovascular Disease (14 Items) This test is based on biochip technology, evaluates the risk of 14 cardiovascular and cerebrovascular diseases from a genetic perspective, and guides disease prevention.
Human Papillomavirus (HPV) Genotyping Detection Based on microarray technology, it is used for simultaneous testing of 18 high-risk strains and 4 low-risk strains of HPV.